Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2006 1
2011 1
2014 2
2015 3
2016 2
2017 1
2018 1
2019 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Silkworm and spider silk electrospinning: a review.
Belbéoch C, Lejeune J, Vroman P, Salaün F. Belbéoch C, et al. Among authors: vroman p. Environ Chem Lett. 2021;19(2):1737-1763. doi: 10.1007/s10311-020-01147-x. Epub 2021 Jan 4. Environ Chem Lett. 2021. PMID: 33424525 Free PMC article. Review.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Vergote I, Van Nieuwenhuysen E, De Waele S, Vulsteke C, Lamot C, Van den Bulck H, Claes N, Graas MP, Debrock G, Spoormans I, Vuylsteke P, Honhon B, Verhoeven D, De Maeseneer D, Dirix L, Mebis J, Vroman P, Denys H, Martinez Mena C, Pelgrims G, Van Steenberghe M, van Gorp T, Gennigens C. Vergote I, et al. Among authors: vroman p. Int J Gynecol Cancer. 2022 Jun 6;32(6):753-760. doi: 10.1136/ijgc-2021-003190. Int J Gynecol Cancer. 2022. PMID: 35063943 Clinical Trial.
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer.
Lambrechts S, Lambrechts D, Despierre E, Van Nieuwenhuysen E, Smeets D, Debruyne PR, Renard V, Vroman P, Luyten D, Neven P, Amant F, Leunen K, Vergote I; Belgian and Luxembourg Gynaecological Oncology Group (BGOG). Lambrechts S, et al. Among authors: vroman p. BMC Pharmacol Toxicol. 2015 Feb 27;16:2. doi: 10.1186/s40360-015-0001-5. BMC Pharmacol Toxicol. 2015. PMID: 25881102 Free PMC article.
Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma.
Duerinck J, Clement PM, Bouttens F, Andre C, Neyns B, Staelens Y, Van Fraeyenhove F, Baurain JF, Luce S, D'hondt L, Joosens E, Specenier P, Verschaeve V, Filleul B, Vroman P, Stragier B, Rogiers A. Duerinck J, et al. Among authors: vroman p. J Neurol. 2015 Mar;262(3):742-51. doi: 10.1007/s00415-014-7633-z. Epub 2015 Jan 9. J Neurol. 2015. PMID: 25572162
15 results